Dive Into Other Topics

Nov 13, 2023

Servier’s Tibsovo has received FDA approval for patients diagnosed with R/R myelodysplastic syndromes that exhibit an IDH1 mutation.

Nov 10, 2023

Roche’s Vabysmo secures new FDA nod for retinal vein occlusion treatment, intensifying competition with Regeneron and Bayer’s Eylea.

Nov 08, 2023

The Energy-Based Aesthetic Devices market stands at the forefront of the evolving landscape of cosmetic treatments, offering a comprehensive range of solutions for individuals seeking non-invasive and minimally invasive procedures to enhance their appearance. Over the past few years, intense advancements in technol...

Nov 06, 2023

Coherus and Junshi received FDA approval for Loqtorzi, marking significant milestone as first-ever nasopharyngeal carcinoma treatment.

Nov 03, 2023

The dynamics of the Niemann-Pick Disease Type C treatment market are expected to change owing to the emerging therapies by key companies.

Nov 01, 2023

Molecular modeling, a revolutionary branch of science that seeks to understand and manipulate the intricate world of molecules at the atomic and molecular levels, has seen a remarkable transformation in recent years, owing to the growth in technology. The union of computational science, chemistry, and biology has g...

Oct 30, 2023

There are several bone sarcoma types, originating from different cells within bone structure and require specialized diagnosis and treatment

Oct 27, 2023

Future of gene therapies for hemophilia B treatment holds great promise, offering the potential for a paradigm shift in treatment approaches.

Oct 25, 2023

Insulin Pens Market is generating huge demand due to rising prevalence of diabetes. Companies are developing innovative Insulin Pens.

Oct 23, 2023

Following two prior rejections, FDA has granted long-awaited approval to Ardelyx's Xphozah for chronic kidney disease treatment in adults.